Bexsero is a vaccine developed to provide protection against invasive meningococcal B infections caused by Neisseria meningitidis serogroup B. The vaccine stimulates the immune system to produce antibodies specific to the B strain, helping prevent severe diseases such as meningitis and septicemia.
Suitable for
Bexsero is recommended for individuals, including infants, adolescents, and adults, who are at an increased risk of meningococcal B infection. This risk may be influenced by factors such as age, certain medical conditions, or specific populations experiencing outbreaks.
The vaccine is typically administered as a series of doses, with the specific dosing schedule influenced by factors such as age, individual risk, and regional immunization guidelines.
Not applicable / Side Effect
Not applicable to people who have a fever or are taking antibiotics on the day of injection
Common side effects may include pain or swelling at the injection site, fever, and irritability. Severe adverse reactions are rare but possible. Post-vaccination monitoring is standard practice.